{"id":"https://openalex.org/W2214495331","doi":null,"title":"\u5f37\u529b\u304b\u3064\u6301\u7d9a\u7684\u306a\u65b0\u898f\u30a2\u30f3\u30b8\u30aa\u30c6\u30f3\u30b7\u30f3AT 1 \u53d7\u5bb9\u4f53\u30d6\u30ed\u30c3\u30ab\u30fcAzilsartan\u306e\u85ac\u52b9\u85ac\u7406\u4f5c\u7528","display_name":"\u5f37\u529b\u304b\u3064\u6301\u7d9a\u7684\u306a\u65b0\u898f\u30a2\u30f3\u30b8\u30aa\u30c6\u30f3\u30b7\u30f3AT 1 \u53d7\u5bb9\u4f53\u30d6\u30ed\u30c3\u30ab\u30fcAzilsartan\u306e\u85ac\u52b9\u85ac\u7406\u4f5c\u7528","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2214495331","mag":"2214495331"},"language":"ja","primary_location":{"id":"mag:2214495331","doi":null,"is_oa":false,"landing_page_url":"http://www.pieronline.jp/content/article/0386-3603/40020/125","pdf_url":null,"source":{"id":"https://openalex.org/S4306557809","display_name":"\u85ac\u7406\u3068\u6cbb\u7642","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u85ac\u7406\u3068\u6cbb\u7642","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017967625","display_name":"\u91d1\u5ddd\u73b2","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"\u91d1\u5ddd\u73b2","raw_affiliation_strings":["\u6b66\u7530\u85ac\u54c1\u5de5\u696d\u682a\u5f0f\u4f1a\u793e\u533b\u85ac\u7814\u7a76\u672c\u90e8\u3000\u4ee3\u8b1d\u75be\u60a3\u5275\u85ac\u30e6\u30cb\u30c3\u30c8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u6b66\u7530\u85ac\u54c1\u5de5\u696d\u682a\u5f0f\u4f1a\u793e\u533b\u85ac\u7814\u7a76\u672c\u90e8\u3000\u4ee3\u8b1d\u75be\u60a3\u5275\u85ac\u30e6\u30cb\u30c3\u30c8","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":null,"display_name":"\u5c0f\u5cf6\u307e\u307f","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5c0f\u5cf6\u307e\u307f","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033125585","display_name":"\u5fd7\u6210 \u5c71\u53e3","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5c71\u53e3\u53f2\u6210","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153305200","display_name":"\u85e4\u539f\u79c0\u53f8","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u85e4\u539f\u79c0\u53f8","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039680899","display_name":"Mitsuaki Imanishi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u4eca\u897f\u4e09\u660e","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153362250","display_name":"\u576a\u4e95\u7dbe\u5b50","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u576a\u4e95\u7dbe\u5b50","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035831326","display_name":"\u5e78\u5b50 \u5869\u8c37","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5869\u8c37\u7d17\u77e5\u5b50","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076309153","display_name":"\u5c0f\u539f\u5eb7\u4e45","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u5c0f\u539f\u5eb7\u4e45","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066862690","display_name":"\u4e45\u4fdd\u6075\u53f8","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u4e45\u4fdd\u6075\u53f8","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017415598","display_name":"\u91ce\u7530\u660c\u90a6","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u91ce\u7530\u660c\u90a6","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027160453","display_name":"\u4e95\u6751\u826f\u8996","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u4e95\u6751\u826f\u8996","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088701014","display_name":"\u9577\u5c4b\u79c0\u660e","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u9577\u5c4b\u79c0\u660e","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034728533","display_name":"Keiji Kusumoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u6960\u672c\u5553\u53f8","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"2","first_page":"125","last_page":"135"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azilsartan","display_name":"azilsartan","score":1.0},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9559999704360962},{"id":"https://openalex.org/keywords/olmesartan-medoxomil","display_name":"olmesartan medoxomil","score":0.9259999990463257},{"id":"https://openalex.org/keywords/candesartan-cilexetil","display_name":"candesartan cilexetil","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antihypertensive-effect","display_name":"antihypertensive effect","score":0.984000027179718},{"id":"https://openalex.org/keywords/essential-hypertension","display_name":"essential hypertension","score":0.8180000185966492},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.5590000152587891},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.9120000004768372},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.7639999985694885},{"id":"https://openalex.org/keywords/angiotensin-ii-pressor-response","display_name":"angiotensin II pressor response","score":0.8009999990463257},{"id":"https://openalex.org/keywords/renal-hypertension","display_name":"renal hypertension","score":0.46299999952316284},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.765999972820282},{"id":"https://openalex.org/keywords/antiproteinuric-effect","display_name":"antiproteinuric effect","score":0.6620000004768372}],"concepts":[{"id":"https://openalex.org/C2779766728","wikidata":"https://www.wikidata.org/wiki/Q421156","display_name":"Olmesartan","level":3,"score":0.9141688346862793},{"id":"https://openalex.org/C2780036600","wikidata":"https://www.wikidata.org/wiki/Q415970","display_name":"Candesartan","level":4,"score":0.8639233708381653},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6749564409255981},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6323619484901428},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5925685167312622},{"id":"https://openalex.org/C2776174234","wikidata":"https://www.wikidata.org/wiki/Q974792","display_name":"Albuminuria","level":3,"score":0.5871159434318542},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.47308045625686646},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.46282416582107544},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.41222143173217773},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3766779899597168}],"mesh":[],"locations_count":2,"locations":[{"id":"mag:2214495331","doi":null,"is_oa":false,"landing_page_url":"http://www.pieronline.jp/content/article/0386-3603/40020/125","pdf_url":null,"source":{"id":"https://openalex.org/S4306557809","display_name":"\u85ac\u7406\u3068\u6cbb\u7642","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u85ac\u7406\u3068\u6cbb\u7642","raw_type":null},{"id":"mag:2999640794","doi":null,"is_oa":false,"landing_page_url":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201202237823336940","pdf_url":null,"source":{"id":"https://openalex.org/S4306557809","display_name":"\u85ac\u7406\u3068\u6cbb\u7642","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u85ac\u7406\u3068\u6cbb\u7642","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1985560249","https://openalex.org/W2091605676","https://openalex.org/W2317486606","https://openalex.org/W2565294201","https://openalex.org/W2405662441","https://openalex.org/W2053393875","https://openalex.org/W3048921721","https://openalex.org/W2404666956","https://openalex.org/W4211106672","https://openalex.org/W2583726657"],"abstract_inverted_index":{"Objective\u3000To":[0],"clarify":[1],"pharmacological":[2],"properties":[3],"of":[4,39,57,62,72,81,98,115,119,140,168,214],"a":[5,70,187,196,236,241],"novel":[6],"angiotensin\u2161":[7,125],"type":[8,26],"1":[9],"receptor":[10],"blocker\uff08ARB\uff09,":[11],"azilsartan,":[12],"we":[13,53,89],"conducted":[14],"several":[15],"in":[16,35,65,83,129,192,228],"vivo":[17,36],"experiments":[18],"using":[19,100],"normal":[20],"rats,hypertensive":[21],"rats":[22,29,68],"and":[23,25,43,94,102,132,142,154,159,175,203],"dogs":[24],"2":[27],"diabetic":[28,104],"exhibiting":[30,107],"overt":[31,108],"albuminuria.Methods\u3000We":[32],"first":[33],"evaluated":[34],"antagonistic":[37],"activities":[38],"orally":[40],"administered":[41],"azilsartan":[42,82,99,116,146,169,194,234],"launched":[44],"ARBs,":[45],"olmesartan":[46],"medoxomil\uff08O.\u3000M.\uff09and":[47],"candesartan":[48],"cilexetil\uff08C.\u3000C.\uff09in":[49],"normotensive":[50,130],"rats.":[51],"Second,":[52],"clarified":[54],"antihypertensive":[55,79,199,246],"effects":[56,114,225],"single":[58,165],"or":[59,121],"repeated":[60],"administrations":[61],"these":[63],"ARBs":[64],"spontaneously":[66],"hypertensive":[67,85,163],"\uff08SHR\uff09,":[69],"model":[71],"essential":[73],"hypertension.":[74],"We":[75,110],"also":[76,111,220],"confirmed":[77],"the":[78,91,95,113,208],"effect":[80,93,97,135,200],"renal":[84,162],"dogs.":[86],"In":[87,144,161,186],"addition,":[88],"studied":[90],"insulin\uff0dsensitizing":[92],"anti\uff0dalbuminuria":[96],"SHR":[101],"Zucker":[103],"fatty\uff08ZDF\uff09rats":[105],"which":[106],"albuminuria,respectively.":[109],"compared":[112],"with":[117],"those":[118,139],"O.\u3000M.":[120,141,153,158,218],"C.\u3000C.":[122,143,227],"Results\u3000Azilsartan":[123],"inhibited":[124],"\uff0dinduced":[126],"pressor":[127],"responses":[128],"rats,":[131],"its":[133],"inhibitory":[134],"is":[136,235],"longer\uff0dlasting":[137],"than":[138,152,157,201,217,226],"SHRs,":[145,193],"reduced":[147,173,177],"blood":[148],"pressure":[149],"more":[150,155,197,205,222],"potently":[151,206],"persistently":[156],"C.C.":[160],"dogs,":[164],"oral":[166],"administration":[167,182],"at":[170,183],"0.3\uff0d3":[171],"mg\uff0fkg":[172],"BP,":[174],"it":[176,204],"even":[178],"24":[179],"hours":[180],"after":[181],"3":[184],"mg\uff0fkg.":[185],"2\uff0dweek":[188],"repeat":[189],"dosing":[190],"study":[191],"showed":[195],"stable":[198],"O.\u3000M.,":[202],"improved":[207],"glucose":[209],"infusion":[210],"rate,":[211],"an":[212,245],"indicator":[213],"insulin":[215],"sensitivity,":[216],"Azilsartan":[219],"exerted":[221],"potent":[223,237],"antiproteinuric":[224],"ZDF":[229],"rats.Conclusion\u3000These":[230],"results":[231],"suggest":[232],"that":[233,239],"ARB":[238],"has":[240],"favourable":[242],"profile":[243],"as":[244],"agent.":[247]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}